PDT Partners, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$284,000
+5.6%
57,915
-10.7%
0.04%
+79.2%
Q2 2022$269,000
-10.3%
64,876
+25.8%
0.02%
-7.7%
Q1 2022$300,000
-7.7%
51,584
+19.0%
0.03%
+4.0%
Q4 2021$325,000
-82.9%
43,331
-79.5%
0.02%
-81.8%
Q3 2021$1,902,000
-36.0%
211,085
-15.0%
0.14%
-30.5%
Q2 2021$2,974,000
+2.9%
248,473
+7.8%
0.20%
-5.3%
Q1 2021$2,889,000
-20.3%
230,579
-0.7%
0.21%
-15.1%
Q4 2020$3,624,000
+19.9%
232,232
-27.4%
0.24%
+22.5%
Q3 2020$3,023,000
+105.1%
319,926
+94.5%
0.20%
+100.0%
Q2 2020$1,474,000
-0.1%
164,519
-6.6%
0.10%
+9.9%
Q4 2019$1,475,000
-29.3%
176,203
-23.6%
0.09%
-26.6%
Q3 2019$2,087,000
-15.9%
230,628
+0.1%
0.12%
-15.6%
Q2 2019$2,481,000
-25.4%
230,361
+17.4%
0.15%
+6.5%
Q3 2018$3,326,000
-20.6%
196,212
-33.5%
0.14%
-13.2%
Q2 2018$4,189,000
-51.5%
295,006
-35.1%
0.16%
-45.4%
Q1 2018$8,634,000
+11.6%
454,436
-3.6%
0.29%
+29.9%
Q4 2017$7,735,000
+1291.2%
471,649
+340.8%
0.22%
+672.4%
Q1 2017$556,000
+113.8%
107,000
+25.3%
0.03%
+70.6%
Q4 2016$260,000
-57.6%
85,400
-35.5%
0.02%
-52.8%
Q3 2016$613,000
-19.9%
132,400
+0.2%
0.04%
-41.0%
Q2 2016$765,000
+12.3%
132,100
+17.3%
0.06%
+41.9%
Q1 2016$681,000
+52.3%
112,600
+42.1%
0.04%
+330.0%
Q3 2015$447,000
+39.3%
79,216
+174.0%
0.01%
+25.0%
Q2 2015$321,000
-10.6%
28,909
-13.2%
0.01%
-11.1%
Q3 2014$359,000
-48.7%
33,294
-62.9%
0.01%
-50.0%
Q2 2013$700,00089,6470.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders